Vitamin A is known to protect against infections, but it is not established how vitamin A metabolites stimulate the immune system. We have investigated the effects of physiological levels of retinoic acid on the function of normal human T-and B-cells. Surprisingly, we found that the proliferation of B-cells was inhibited by retinoids, and that this was due to rapid inhibition of the cell cycle machinery regulating G 1 -to-S transition. In contrast, the proliferation of T-cells was enhanced by physiological levels of retinoic acid, and the effect was due to induction of IL-2 (interleukin 2). The 'non-death-receptor'-mediated apoptosis of normal T-cells induced by prolonged (but single) stimulation of the cells was also prevented by retinoid acid, and also this effect was mediated via enhanced production of IL-2. The induction of IL-2 was at the transcriptional level, and all the effects of vitamin A on both B-and T-cells were mediated via the nuclear retinoic acid receptors (RARs), and not retinoid X receptors (RXRs).
Vitamin A regulates proliferation and apoptosis of human T-and B-cells Introduction
It has been known for years that an optimal vitamin A status protects against infections. Thus the vitamin A deficiency, frequently observed in developing countries, is believed to be a major cause of child death associated with infectious diseases in these parts of the world [1] . Both in vivo and in vitro studies have documented that vitamin A stimulates the immune system [2] , but the mechanisms responsible are not yet established. We set out to understand how physiological levels of vitamin A affect the different cells of the immune system, and we have so far limited our studies to cultures of normal T-and B-lymphocytes. Vitamin A is metabolized in the body to different forms of retinoids, and of these, RA (all-trans-retinoic acid) and 9-cis-RA are the most active in most cell types. Both these retinoids act by binding to nuclear receptors, known as RARs (retinoic acid receptors) and RXRs (retinoid X receptors), of which there are several different subtypes [3] . These receptors are transcription factors, and the expression of hundreds of genes is found to be regulated (up or down) when cells are exposed to RA or 9-cis-RA [4] . We have shown that human lymphocytes express RARα, RARγ and RXRα, but not RARβ, RXRβ or RXRγ [5] .
The function of T-and B-lymphocytes is regulated both at the level of proliferation and apoptosis [6] . In peripheral blood, both cell types are found resting (in the G 0 state of the cell cycle), and after encountering the antigen, both cell types are stimulated into the cell cycle leading to proliferation. The process leading to cell death, apoptosis, is also highly regulated in normal T-and B-cells, during development of the Key words: apoptosis, cell cycle, human T-and B-cells, interleukin-2, lymphocytes, retinoic acid, vitamin A. Abbreviations used: ACAD, activated T-cell autonomous death; CDK, cyclin-dependent kinase; CKI, CDK inhibitor; IL(-2), interleukin(-2); PHA, phytohaemagglutinin; pRB, retinoblastoma protein;
RA, all-trans-retinoic acid; RAR, retinoic acid receptor, RXR, retinoid X receptor. 1 email h.k.blomhoff@basalmed.uio.no immune system, to prevent autoimmunity and to ensure that only cells that are properly stimulated survive and propagate [6] .
Differential regulation of B-and T-cell proliferation by RA
Several years ago, we demonstrated that the proliferation of normal peripheral blood B-cells [7] and B-cell precursors [8] was inhibited by physiological levels of RA. Later, we were able to show that the inhibitory effect of RA on proliferation of B-cells was due to inhibition of the cell-cycle machinery that regulates the entry of cells into the S-phase [9] .
For a normal cell to enter into S-phase during cell-cycle progression, the cell has to pass the restriction point (R) in G 1 . The key event in this process is the phosphorylation of pRB (retinoblastoma protein) [10] . In early-to mid-G 1 , pRB is hypophosphorylated and, in this state, pRB binds the transcription factors E2Fs [11] . In response to growth factor signalling, CDKs (cyclin-dependent kinases) are activated owing to elevation of specific cyclins and/or inhibition of specific CKIs (CDK inhibitors) [12] . In lymphocytes, CDK4 and CDK6 are activated by cyclin D3, followed by activation of CDK2 bound to cyclins E and A. Furthermore, these CDKs can be stimulated by decreasing the level and/or preventing the binding of the CKIs p21cip and p27kip. When the CDKs are activated during G 1 , E2Fs are released from pRB, and these transcription factors are free to stimulate transcription of genes required for S-phase progression [11] . Using normal human peripheral blood B-lymphocytes, we showed that RA prevented phosphorylation of pRB, at doses as low as 10 nM [9] . The effect of RA appeared primarily to be due to up-regulation of CKI p21cip, and this up-regulation appeared to be at the level of transcription [9] . This led to reduced binding between p21cip and CDK2, which in turn resulted in inhibiting the activity of CDK2. The activity of CDK2 was further reduced by inhibiting the level of cyclin E, resulting in reduced binding of cyclin E to CDK2. We are currently in the process of elucidating the mechanisms whereby RA inhibits the level of cyclin E, since no RARresponsive elements are found in the cyclin E promoter.
It has been reported in several papers that RA stimulates T-lymphoid cells, such as in thymocytes [13, 14] and murine splenic T-cells [15, 16] . Thus it was not surprising to find that physiological levels of RA and 9-cis-RA stimulated the proliferation of normal peripheral blood T-cells, when the cells were co-stimulated with agents such as PMA or PHA (phytohaemagglutinin) [17] . We wished to elucidate the mechanisms by which RA promoted this proliferation and, therefore, examined the regulation of the cell-cycle machinery operating in G 1 . We demonstrated that RA enhanced the PMA-induced phosphorylation of pRB [17] . This was in turn due to increases in the levels of cyclins E and A leading to stimulation of CDK2. In contrast with the rapid effects of RA on the cell-cycle machinery in B-cells (<2 h), the effects of RA on the cell-cycle machinery in T-cells were rather slow (>24 h). This allowed us to speculate that the effects of RA on the cell-cycle machinery were indirect.
One of the factors that is required for proliferation of normal T-cells is IL-2 (interleukin 2) [18] . IL-2 is produced upon stimulation of T-cells, and at the same time as IL-2 receptors are expressed. We found that RA potently enhanced the production of IL-2 from activated T-cells, without affecting the expression of IL-2 receptors. By using neutralizing antibodies against IL-2 receptors, we demonstrated that the enhanced IL-2 production was directly responsible for the RA-mediated changes we observed in the cell-cycle machinery, such as increased levels of cyclins A and E, enhanced activity of CDK2 and induced phosphorylation of pRB [17] .
RA regulates apoptosis in B-and T-cells
Since the overall effect of RA appears to be stimulation of the immune system, the inhibitory effect of RA on proliferation of B-cells was surprising and allowed us to study the regulation of apoptosis in the same cells. In line with the stimulatory effect of RA on the immune system, both RA and 9-cis-RA protected the B-lymphocytes against spontaneous apoptosis of the resting B-cells, and the effects were mediated through RARs and not RXRs [5] . Recently, we have also demonstrated that both RA and 9-cis-RA were capable of preventing stimulated T-cells from undergoing apoptosis [19] . T-cells that are stimulated a single time with antigens, or as in our system with PMA or PHA, will initiate proliferation. If such cells are left without further stimulation they will undergo apoptosis, known as ACAD (activated T-cell autonomous death) [19] . In contrast with activationinduced cell death [20] , this type of T-cell apoptosis does not involve activation of death receptors like Fas. We observed that RA and 9-cis-RA protected the cells from undergoing ACAD, and that the effects were through RARs and not through RXRs. The protective effect of RA against T-cell apoptosis strictly correlated with the ability of RA to enhance IL-2 production. Thus the T-cells isolated from healthy blood donors from Ullevål University Hospital in Oslo were divided into 'high' and 'low' responders to RA. The high responders produced high levels of IL-2 in response to RA, whereas the low responders only produced low levels of IL-2.
Fas-mediated cell death is also an important process in both normal T-and B-cells [20, 21] , and disruption of this type of cell death may lead to autoimmune diseases and malignancies [20, 21] . We have shown that stimulation of malignant T-cells (Jurkat cells) with PMA protects these cells from undergoing Fas-mediated apoptosis via activation of extracellular-signal-regulated kinase and nuclear factor κB [22] . We have demonstrated recently that retinoic acid abrogates the protecting effect of PHA on Fas-mediated apoptosis, and that this effect is not through extracellularsignal-regulated kinase and/or nuclear factor κB. We are currently elucidating the mechanisms involved, such as caspase activation and release of apoptosis-regulating factors from mitochondria.
RA induces IL-2 production
Given the vital role of IL-2 in RA-mediated stimulation of T-cell proliferation and protection against ACAD, we investigated the mechanisms by which IL-2 is produced. We established that the induction of IL-2 was at the level of transcription. Thus, as revealed by mRNA and microarray analysis, the IL-2 mRNA levels were rapidly enhanced upon RA stimulation of PMA-or PHA-treated cells. The stability of IL-2 mRNA was not affected. Reverse transcription-PCR measurements of RA-treated cells confirmed the increased production of IL-2 at the level of mRNA. Since no RAR elements are found in the IL-2 promoter, we are now in the process of elucidating the mechanisms involved in RAmediated transcription of IL-2. To get some indications as to the signalling pathways that might be involved, we have performed recently micro-array analysis of PMAstimulated T-cells that are treated with RA. Several potentially interesting genes were found to be regulated by RA, and the relevance of these changes in gene expression is being investigated.
Conclusions
Based on our studies on the effects of physiological levels of retinoic acid on normal human B-and T-lymphocytes, we believe that vitamin A-mediated stimulation of the immune system first of all is attributable to its effect on the T-cells. This conclusion is based on the fact that the major effect of retinoids on B-cells was a pronounced inhibition of the proliferation, whereas the proliferation was enhanced, and apoptosis was reduced, by retinoic acid in T-cells. The selective induction of IL-2 in T-cells might explain the differential response to retinoids in T-and B-cells.
